F
Ford Motor Company
F has lower modeled downside risk, despite its lower overall score.
XPEV
XPeng Inc.
XPEV has a slight edge over F overall, supported by stronger fundamentals and stronger modeled upside.
F Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Under pressure | |
| Strong |
F's balance sheet is currently strong, and its revenue is stable, but its profitability and cash flow are under pressure.
XPEV Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Stable | |
| Unavailable |
XPEV's revenue and cash flow are currently stable, but its profitability is under pressure. There isn't enough data to rate its balance sheet.
F PE Valuation
F has no meaningful PE right now: it lost money over the past year.
XPEV PE Valuation
XPEV has no meaningful PE right now: it lost money over the past year.
F Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Stable | |
| Improving | |
| Limited | |
| Low |
Analysts expect F's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
XPEV Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Improving | |
| Limited | |
| Low |
XPEV has the edge over F on the outlook, with more favorable revenue expectations.
F Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.78 | — |
| Q3 2026 | -$1.97 | -270% |
| Q2 2026 | -$1.87 | -340% |
| Q1 2026 | -$1.55 | -224% |
| Q4 2025 | -$2.06 | -241% |
| Q3 2025 | $1.16 | +32% |
| Q2 2025 | $0.78 | -19% |
| Q1 2025 | $1.25 | +29% |
| Q4 2024 | $1.46 | +35% |
F has swung to a loss: it lost $1.97 per share over the past year, after a profit the year before.
XPEV Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.93 | -$0.25 |
| Q1 2026 | -$0.58 | +$0.23 |
| Q4 2025 | -$0.12 | +$0.80 |
| Q3 2025 | -$0.45 | +$0.47 |
| Q2 2025 | -$0.68 | +$0.63 |
| Q1 2025 | -$0.81 | +$0.79 |
| Q4 2024 | -$0.92 | +$0.87 |
| Q3 2024 | -$0.92 | +$1.07 |
XPEV has the edge over F on earnings, with more consistent year-over-year improvement.
F Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $49.5B | -2% |
| Q2 2026 | $48.3B | -3.8% |
| Q1 2026 | $43.3B | +6.4% |
| Q4 2025 | $45.9B | -4.8% |
| Q3 2025 | $50.5B | +9.4% |
| Q2 2025 | $50.2B | +5% |
| Q1 2025 | $40.7B | -5% |
| Q4 2024 | $48.2B | +4.9% |
F's revenue grew through 2023 and has held roughly level since: $49.5B last quarter, down 2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.9% | -0.1 points |
| Q2 2026 | 1.3% | +0.3 points |
| Q1 2026 | 5.4% | +4.6 points |
| Q4 2025 | -25% | -28 points |
| Q3 2025 | 3.1% | +1.2 points |
| Q2 2025 | 1% | -2.9 points |
| Q1 2025 | 0.8% | -2.1 points |
| Q4 2024 | 2.5% | +3.1 points |
F has the edge over XPEV on profitability, with a higher operating margin.
XPEV Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $3B | +7.7% |
| Q1 2026 | $1.9B | -18% |
| Q4 2025 | $3.3B | +36% |
| Q3 2025 | $3.1B | +102% |
| Q2 2025 | $2.7B | +125% |
| Q1 2025 | $2.4B | +141% |
| Q4 2024 | $2.4B | +23% |
| Q3 2024 | $1.5B | +18% |
XPEV has the edge over F on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -6.7% | -1.6 points |
| Q1 2026 | -16% | -9.6 points |
| Q4 2025 | -4.2% | +5.5 points |
| Q3 2025 | -3.7% | +15 points |
| Q2 2025 | -5.1% | +15 points |
| Q1 2025 | -6.6% | +19 points |
| Q4 2024 | -9.7% | +6.1 points |
| Q3 2024 | -18% | +19 points |
XPEV's operating margin was −6.7% last quarter, down 1.6 points from the same quarter a year ago.
F Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.1B | -40% |
| Q2 2026 | $2B | -54% |
| Q1 2026 | -$1.1B | -157% |
| Q4 2025 | $1.1B | +108% |
| Q3 2025 | $5.3B | +50% |
| Q2 2025 | $4.2B | +24% |
| Q1 2025 | $1.9B | +$2.6B |
| Q4 2024 | $530M | +169% |
F has the edge over XPEV on cash flow, with more consistent year-over-year improvement.
XPEV Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $0 | $0 |
| Q1 2026 | $0 | $0 |
| Q4 2025 | $0 | $0 |
| Q3 2025 | $0 | $0 |
| Q2 2025 | $0 | $0 |
| Q1 2025 | $0 | $0 |
| Q4 2024 | $0 | $0 |
| Q3 2024 | $0 | $0 |
XPEV's free cash flow was $0 over the past year, against $0 the year before.
F Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2.2% | +89M shares |
| 1 year | +0.7% | +28M shares |
| 3 years | +0.6% | +26M shares |
| 5 years | +1% | +40M shares |
| Available history | +1.8% | +72M shares |
F has 4.1B diluted shares, up 0.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $311M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $150M |
F spent $311M buying back its own shares over the past year, up 107% from the year before.
XPEV Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +541K shares |
| 1 year | -49% | -467M shares |
| 3 years | -45% | -383M shares |
| 5 years | -44% | -377M shares |
| Available history | -44% | -377M shares |
XPEV has the edge over F on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
XPEV hasn't bought back shares in the past year.
F Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2.5x | Net Cash |
| Q2 2026 | -2.1x | Net Cash |
| Q1 2026 | -2.0x | Net Cash |
| Q4 2025 | -3.4x | Net Cash |
| Q3 2025 | -2.4x | Net Cash |
| Q2 2025 | -2.2x | Net Cash |
| Q1 2025 | -1.8x | Net Cash |
| Q4 2024 | -1.8x | Net Cash |
F has more cash than debt.
XPEV Net Leverage
XPEV's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
F Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.5 | Neutral |
| Stochastic | 19.6 | Oversold |
F's weekly RSI is 41 (neutral) and its Stochastic is 20 (oversold).
XPEV Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 35.5 | Neutral |
| Stochastic | 17.7 | Oversold |
XPEV's weekly RSI is 36 (neutral) and its Stochastic is 18 (oversold).
F PE vs Consumer Cyclical Sector
| Metric | F | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
F has no meaningful PE right now: it lost money over the past year.
XPEV PE vs Consumer Cyclical Sector
XPEV has no meaningful PE right now: it lost money over the past year.
F Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $12.2 | 2.5% below |
| 20 week MA | $13.3 | 11% below |
| 50 week MA | $13.4 | 11% below |
| 100 week MA | $12.1 | 2% below |
| 200 week MA | $12.1 | 1.4% below |
F is in a downtrend: it's below all five of its weekly moving averages, and 1.4% below its 200-week average.
XPEV Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $9.56 | 1% below |
| 20 week MA | $11.1 | 14% below |
| 50 week MA | $14.9 | 37% below |
| 100 week MA | $17.2 | 45% below |
| 200 week MA | $14.2 | 33% below |
XPEV is in a downtrend: it's below all five of its weekly moving averages, and 33% below its 200-week average.
F Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.36 | $8.86 | -5.3% |
| 2021 | $8.86 | $20.3 | +129% |
| 2022 | $20.3 | $11.4 | -44% |
| 2023 | $11.4 | $12.2 | +7.3% |
| 2024 | $12.2 | $10.0 | -18% |
| 2025 | $10.0 | $13.3 | +33% |
| 2026 YTD | $13.3 | $11.9 | -11% |
F has the edge over XPEV on returns for 2026, with the stronger performance.
XPEV Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $22.8 | $41.9 | +84% |
| 2021 | $41.9 | $46.1 | +10% |
| 2022 | $46.1 | $10.1 | -78% |
| 2023 | $10.1 | $14.6 | +45% |
| 2024 | $14.6 | $12.6 | -13% |
| 2025 | $12.6 | $20.8 | +65% |
| 2026 YTD | $20.8 | $9.46 | -54% |
XPEV is down 54% so far in 2026, after finishing higher in four of the previous six years.